1.
Clark, RH, Bloom, BT, Spitzer, AR, Gerstmann, DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics
2006;117:1979–1987.
2.
Fonseca, SN, Ehrenkranz, RA, Baltimore, RS. Epidemiology of antibiotic use in a neonatal intensive care unit. Infect Control Hosp Epidemiol
1994;15:156–162.
3.
Wirtschafter, DD, Padilla, G, Suh, O, Wan, K, Trupp, D, Fayard, EE. Antibiotic use for presumed neonatally acquired infections far exceeds that for central line-associated blood stream infections: an exploratory critique. J Perinatol
2011;31:514–518.
4.
Cantey, JB, Wozniak, PS, Sanchez, PJ. Prospective surveillance of antibiotic use in the neonatal intensive care unit: results from the SCOUT study. Pediatr Infect Dis J
2015;34:267–272.
5.
Almuneef, MA, Baltimore, RS, Farrel, PA, Reagan-Cirincione, P, Dembry, LM. Molecular typing demonstrating transmission of gram-negative rods in a neonatal intensive care unit in the absence of a recognized epidemic. Clin Infect Dis
2001;32:220–227.
6.
Bizzarro, MJ, Gallagher, PG. Antibiotic-resistant organisms in the neonatal intensive care unit. Semin Perinatol
2007;31:26–32.
7.
Patel, SJ, Saiman, L. Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship. Clin Perinatol
2010;37:547–563.
8.
Shane, AL, Stoll, BJ. Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. Am J Perinatol
2013;30:131–141.
9.
Aliaga, S, Clark, RH, Laughon, M, et al. Changes in the incidence of candidiasis in neonatal intensive care units. Pediatrics
2014;133:236–242.
10.
Tripathi, N, Cotten, CM, Smith, PB. Antibiotic use and misuse in the neonatal intensive care unit. Clin Perinatol
2012;39:61–68.
11.
Alexander, VN, Northrup, V, Bizzarro, MJ. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr
2011;159:392–397.
12.
Cotten, CM, Taylor, S, Stoll, B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics
2009;123:58–66.
13.
Kuppala, VS, Meinzen-Derr, J, Morrow, AL, Schibler, KR. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr
2011;159:720–725.
15.
Barlam, TF, Cosgrove, SE, Abbo, LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis
2016;62:e51–e77.
16.
Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, Pediatric Infectious Diseases Society. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol
2012;33:322–327.
18.
Newland, JG, Stach, LM, De Lurgio, SA, et al. Impact of a prospective-audit-with-feedback antimicrobial stewardship program at a children’s hospital. J Pediatric Infect Dis Soc
2012;1:179–186.
19.
Di Pentima, MC, Chan, S, Hossain, J. Benefits of a pediatric antimicrobial stewardship program at a children’s hospital. Pediatrics
2011;128:1062–1070.
20.
Metjian, TA, Prasad, PA, Kogon, A, Coffin, SE, Zaoutis, TE. Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J
2008;27:106–111.
21.
Patel, SJ, Saiman, L. Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit. Semin Perinatol
2012;36:431–436.
23.
Kliegman, RM, Walsh, MC. Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr
1987;17:213–288.
24.
Polin, RA; Committee on fetus and newborn. Management of infants with suspected or proven early-onset bacterial sepsis. Pediatrics
2012;129:1006–1115.
25.
American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 485: prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol
2011;117:1019–1027.
26.
Brady, MT, Polin, RA. Prevention and management of infants with suspected or proven neonatal sepsis. Pediatrics
2013;132:166–168.
28.
Schulman, J, Dimand, RJ, Lee, HC, Duenas, GV, Bennett, MV, Gould, JB. Neonatal intensive care unit antibiotic use. Pediatrics
2015;135:826–833.
29.
Patel, SJ, Oshodi, A, Prasad, P, et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 step campaign to prevent antimicrobial resistance. Pediatr Infect Dis J
2009;28:1047–1051.
30.
Patel, SJ, Rosen, E, Zaoutis, T, Prasad, P, Saiman, L. Neonatologists’ perceptions of antimicrobial resistance and stewardship in neonatal intensive care units. Infect Control Hosp Epidemiol
2010;31:1298–1300.
31.
Kiser, C, Nawab, C, McKenna, K, Aghai, ZA. Role of guidelines on length of therapy in chorioamnionitis in neonatal sepsis. Pediatrics
2014;133:992–998.
32.
Higgins, RD, Saade, G, Polin, RA, et al. Evaluation and management of newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop. Obstet Gynecol
2016;127:426–436.
33.
Kuzniewicz, MW, Puopolo, KM, Fischer, A, et al. A quantitative approach to the management of neonatal early-onset sepsis. JAMA Pediatr
2017;171:365–371.
34.
Bizzarro, MJ, Shabanova, V, Baltimore, RS, Dembry, LM, Ehrenkranz, RA, Gallagher, PG. Neonatal sepsis, 2004–2013; the rise and fall of coagulase-negative staphylococci. J Pediatr
2015;166:1193–1199.
35.
Cantey, JB, Patel, SJ. Antimicrobial stewardship in the NICU. Infect Dis Clin North Am
2014;28:247–261.